[Evaluation of strength in amyotrophic lateral sclerosis].
The hallmark of progression in patients with amyotrophic lateral sclerosis (ALS) is the development of progressive weakness and muscular wasting. Strength testing has been used to monitor the course of the disease and to test the efficacy of new drugs. This paper review the methods used to quantify the weakness and compare their accuracy and reproducibility.
Campana-Salort
E
E
Centre Référent pour la SLA de Bordeaux, CHU Haut Lévêque, Pessac. emmanuelle.salort@chu-bordeaux.fr
D000690:Amyotrophic Lateral Sclerosis / Q000503:physiopathology*; D006801:Humans; D009119:Muscle Contraction; D053580:Muscle Strength; D053581:Muscle Strength Dynamometer